Continuous intra-arterial application of substance P induces signs and symptoms of experimental complex regional pain syndrome (CRPS) such as edema, inflammation and mechanical pain but no thermal pain.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Neuroscience

• Publication date

  2007-09-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.NEUROSCIENCE.2007.06.024PMID 17686587
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Complex regional pain syndrome: diagnostic controversies, psychological dysfunction, and emerging concepts.

  2006cited by this paper
• Exaggeration of tissue trauma induces signs and symptoms of acute CRPS I, however displays distinct differences to experimental CRPS II.

  2006cited by this paper
• Noninvasive assessment of cutaneous vascular function in vivo using capillaroscopy, plethysmography and laser-Doppler instruments: Its strengths and weaknesses

  2006cited by this paper
• Antinociceptive action of the extract and the flavonoid quercitrin isolated from Bauhinia microstachya leaves

  2005cited by this paper
• Complex regional pain syndrome

  2005cited by this paper
• SUPERNATANT OF TRAUMATIZED MUSCLE INDUCES INFLAMMATION AND PAIN, BUT NOT MICROCIRCULATORY PERFUSION FAILURE AND APOPTOTIC CELL DEATH

  2005cited by this paper
• Excitation of cutaneous afferent nerve endings in vitro by a combination of inflammatory mediators and conditioning effect of substance P

  2004cited by this paper
• Substance P and neurotensin are up-regulated in the lumbar spinal cord of animals with neuropathic pain.

  2004cited by this paper
• Substance P signaling contributes to the vascular and nociceptive abnormalities observed in a tibial fracture rat model of complex regional pain syndrome type I

  2004cited by this paper
• The role of substance P in inflammatory disease

  2004cited by this paper
• In vivo evidence for apoptosis, but not inflammation in the hindlimb muscle of neuropathic rats

  2004cited by this paper
• Involvement of peripherally released substance P and calcitonin gene-related peptide in mediating mechanical hyperalgesia in a traumatic neuropathy model of the rat.

  2004cited by this paper
• Substance-P-induced protein extravasation is bilaterally increased in complex regional pain syndrome.

  2003cited by this paper
• A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II

  2003cited by this paper
• Functional role of exogenous administration of substance P in chronic constriction injury model of neuropathic pain in gerbils.

  2003cited by this paper
• [Why are substance P(NK1)-receptor antagonists ineffective in pain treatment?].

  2002cited by this paper
• [Complex regional pain syndrome. Reflex sympathetic dystrophy and causalgia].

  2002cited by this paper
• Warum versagen Substanz P (NK1)-Rezeptorantagonisten in der Schmerztherapie?

  2002cited by this paper
• A study of bone densitometry in patients with complex regional pain syndrome after stroke

  2001cited by this paper
• Influence of painful chronic neuropathy on neurogenic inflammation

  2001cited by this paper
• Facilitated neurogenic inflammation in complex regional pain syndrome

  2001cited by this paper
• The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex.

  2000cited by this paper
• Specific Inhibition of Glucocorticoid-Induced Thymocyte Apoptosis by Substance P1

  2000cited by this paper
• In vivo analysis of microcirculation following closed soft‐tissue injury

  1999cited by this paper
• Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids.

  1999cited by this paper
• Bone atrophy in complex regional pain syndrome patients measured by microdensitometry

  1998cited by this paper
• [Cap image--a new kind of computer-assisted video image analysis system for dynamic capillary microscopy].

  1997cited by this paper
• Intra-arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerability.

  1997cited by this paper
• High-resolution microscopic determination of hepatic NADH fluorescence for in vivo monitoring of tissue oxygenation during hemorrhagic shock and resuscitation.

  1997cited by this paper
• Adhesion molecules as determinants of disease: From molecular biology to surgical research

  1996cited by this paper
• Quantitative assessment of tactile allodynia in the rat paw.

  1994cited by this paper
• Scope and perspectives of intravital microscopy--bridge over from in vitro to in vivo.

  1993cited by this paper
• Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin.

  1993cited by this paper
• An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat

  1992cited by this paper
• A new preparation of rat extensor digitorum longus muscle for intravital investigation of the microcirculation.

  1991cited by this paper
• Further evidence for ‘pain‐related’ behaviours in a model of unilateral peripheral mononeuropathy

  1990cited by this paper
• Substance P induces the expression of an endothelial-leukocyte adhesion molecule by microvascular endothelium.

  1990cited by this paper
• Effect of neuropeptides on production of inflammatory cytokines by human monocytes.

  1989cited by this paper
• Substance P primes human neutrophil activation: a mechanism for neurological regulation of inflammation.

  1989cited by this paper
• Effect of neuropeptides on production of inflammatory cytokines by human monocytes

  1988cited by this paper
• Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen.

  1986cited by this paper

• Comprehensive Mechanisms and Non-Invasive Treatment for Complex Regional Pain Syndrome: A Narrative Review

  2025cites this paper
• The Role of Microcirculatory Dysfunction During Paclitaxel Treatment as a Critical Co-Factor for the Development of Chemotherapy-Induced Peripheral Neuropathy

  2024cites this paper
• Animal Models of Complex Regional Pain Syndrome: A Scoping Review.

  2023cites this paper
• I Surgical Biology CHAPTER 1 Inflammatory Response

  2017cites this paper
• Estrogen receptors involvement in intervertebral discogenic pain of the elderly women: colocalization and correlation with the expression of Substance P in nucleus pulposus

  2017cites this paper
• Identification and Treatment of New Inflammatory Triggers for Complex Regional Pain Syndrome: Small Intestinal Bacterial Overgrowth and Obstructive Sleep Apnea.

  2016cites this paper
• The therapeutic potential of renin angiotensin aldosterone system (RAAS) in chronic pain: from preclinical studies to clinical trials

  2016influential citation
• Interaction of calcitonin gene related peptide (CGRP) and substance P (SP) in human skin.

  2016cites this paper
• HIV/AIDS Neuropathy

  2016cites this paper
• Complex regional pain syndrome: a comprehensive and critical review.

  2014cites this paper
• Pathologische Frakturen, systemische Erkrankungen, Infektionen, Tumore und posttraumatische Syndrome des Fußes

  2014cites this paper
• Renin–angiotensin system in pain: Existing in a double life?

  2014cites this paper
• Blockade of substance P receptor attenuates osteoporotic pain, but not bone loss, in ovariectomized mice

  2013cites this paper
• Neuropeptide deficient mice have attenuated nociceptive, vascular, and inflammatory changes in a tibia fracture model of complex regional pain syndrome

  2012cites this paper
• Inflaming the Brain: CRPS a Model Disease to Understand Neuroimmune Interactions in Chronic Pain

  2012cites this paper
• Spinal cord stimulation in neuropathic pain technical aspects and effectiveness

  2011cites this paper
• Vasomotor disturbances in complex regional pain syndrome--a review.

  2010cites this paper
• The association between ACE inhibitors and the complex regional pain syndrome: Suggestions for a neuro‐inflammatory pathogenesis of CRPS

  2009cites this paper
• Current Understandings on Complex Regional Pain Syndrome

  2009cites this paper
• Chapter 40 – COMPLEX REGIONAL PAIN SYNDROME PATHOPHYSIOLOGY

  2009cites this paper
• Systemic inflammatory mediators in post-traumatic Complex Regional Pain Syndrome (CRPS I) - longitudinal investigations and differences to control groups

  2009cites this paper
• Sensory-nerve-derived neuropeptides: possible therapeutic targets.

  2009cites this paper
• Status of immune mediators in complex regional pain syndrome type I

  2008cites this paper
• Sympathetic vasoconstrictor antagonism and vasodilatation relieve mechanical allodynia in rats with chronic postischemia pain.

  2008cites this paper
• Six Years Follow-up of the Levels of TNF-α and IL-6 in Patients with Complex Regional Pain Syndrome Type 1

  2008cites this paper
• Pathophysiology of complex regional pain syndrome

  2006cites this paper
• Available online at www.sciencedirect.com Role of NFkB in an Animal Model of Complex Regional Pain Syndrome–type I (CRPS-I)

  year unknowncites this paper